Literature DB >> 33954203

Corrigendum to "The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast".

Yangyang Li1, Yongfeng Zhang2, Weiqi Meng2, Yutong Li1, Tao Huang3, Di Wang2, Min Hu1.   

Abstract

[This corrects the article DOI: 10.1155/2020/9467683.].
Copyright © 2021 Yangyang Li et al.

Entities:  

Year:  2021        PMID： 33954203      PMCID： PMC8068548          DOI： 10.1155/2021/9824165

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


In the article titled “The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast” [1], the authors identified a mistake in Figure 1, where panel 2 of the liver samples was duplicated with panel 6. The authors confirm that this does not affect the results and conclusions of the article, and the corrected Figure 1 is as follows:
Figure 1

Effects of YSBGY on the structures of the liver, spleen, and kidney of OP mice visualized by H&E staining (n = 6; 200x, scale bar: 50 μm).

  1 in total

1.  The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast.

Authors:  Yangyang Li; Yongfeng Zhang; Weiqi Meng; Yutong Li; Tao Huang; Di Wang; Min Hu
Journal:  Biomed Res Int       Date:  2020-02-19       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.